2023 annual financial data
X4 Pharmaceuticals 2023 Operating margin
X4 Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -107,522,000 USD and net income was -101,167,000 USD.
Operating cash flow was -96,512,000 USD.
Get free X4 Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -107,522,000 USD
- Net income
- -101,167,000 USD
- Operating cash flow
- -96,512,000 USD